scholarly journals The Morphophysiological, Histological, and Biochemical Response of Some Nontarget Organisms to the Stress Induced by the Pesticides in the Environment

2019 ◽  
Author(s):  
Liliana Cristina Soare ◽  
Alina Păunescu ◽  
Ponepal Cristina Maria
Keyword(s):  
Biochemical Response ◽  
Nontarget Organisms

What habitat does spiny snout mite occupy in Tasmania

2015 ◽  
Vol 68 ◽  
pp. 446-446
Author(s):  
D.J. Wilson ◽  
P.J. Gerard
Keyword(s):  
New Zealand ◽  
Sand Dune ◽  
Biocontrol Agent ◽  
Predatory Mites ◽  
Mite Species ◽  
Predatory Mite ◽  
Habitat Specificity ◽  
Nontarget Organisms ◽  
Flea Control ◽  
Potential Biocontrol Agent

Spiny snout mite (Neomolgus capillatus) is a potential biocontrol agent for clover flea (Sminthurus viridis) a white clover pest on dairy farms in warmer and wetter parts of New Zealand In the 1990s this mite was introduced from Brittany France into Tasmania for clover flea control Results during the release programme were highly promising and subsequent anecdotal farmer reports indicate widespread decreases in damage As N capillatus is a predatory mite and already known to attack nontarget organisms habitat specificity will determine whether it could be introduced into New Zealand without risk to native insects To assess this pastures on nine of the original Tasmanian release farms and adjacent nontarget habitats ranging from bush wetlands eucalypt stands to sand dune country were sampled in April 2014 Litter samples were collected heat extracted and mite species identified Neomolgus capillatus was found at effective densities in pastures that had good clover cover Where present it displaced Bdellodes spp mites that are ineffective against clover flea No N capillatus were found in the nontarget habitats all of which lacked clover and contained other predatory mites including Bdellodes spp Therefore the preference by N capillatus for lush pastures makes it an excellent prospect for introduction as a biocontrol agent into clover flea prone regions of New Zealand

AZT: A Biochemical Response Modifier of Methotrexate and 5-Fluorouracil Cytotoxicity in Human Ovarian and Pancreatic Carcinoma Cells

1991 ◽  
Vol 3 (4) ◽  
pp. 127-132 ◽  
Author(s):  
George Weber ◽  
Masami Nagai ◽  
Noemi Prajda ◽  
Hiroyuki Nakamura ◽  
Thomas Szekeres ◽  
...  
Keyword(s):  
Pancreatic Carcinoma ◽  
Carcinoma Cells ◽  
Biochemical Response ◽  
Response Modifier

Biochemical Response of Soybean Roots to f. sp. Infection

Crop Science ◽  
2004 ◽  
Vol 44 (3) ◽  
pp. 819 ◽  
Author(s):  
V. V. Lozovaya ◽  
A. V. Lygin ◽  
S. Li ◽  
G. L. Hartman ◽  
J. M. Widholm
Keyword(s):  
Biochemical Response ◽  
Soybean Roots

scholarly journals The Growth, Physiological and Biochemical Response of Foxtail Millet to Atrazine Herbicide

2021 ◽  
Author(s):  
Alam Sher ◽  
Muhammad Mudassir Maqbool ◽  
Javed Iqbal ◽  
Muhammad Nadeem ◽  
Sajid Faiz ◽  
...  
Keyword(s):  
Foxtail Millet ◽  
Biochemical Response ◽  
Physiological And Biochemical

scholarly journals THE BIOCHEMICAL RESPONSE TO TRAUMA

1955 ◽  
Vol 215 (2) ◽  
pp. 669-676
Author(s):  
William J. Jordan ◽  
Irving Gray
Keyword(s):  
Biochemical Response

scholarly journals Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy

Diagnostics ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 428
Author(s):  
Friederike Völter ◽  
Lena Mittlmeier ◽  
Astrid Gosewisch ◽  
Julia Brosch-Lenz ◽  
Franz Josef Gildehaus ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Single Photon ◽  
Photon Emission ◽  
Whole Body ◽  
Biochemical Response ◽  
Emission Computed Tomography ◽  
Radioligand Therapy ◽  
Index Lesion ◽  
Recist 1.1 ◽  
Psma Pet

Background: Dosimetry can tailor prostate-specific membrane-antigen-targeted radioligand therapy (PSMA-RLT) for metastatic castration-resistant prostate cancer (mCRPC). However, whole-body tumor dosimetry is challenging in patients with a high tumor burden. We evaluate a simplified index-lesion-based single-photon emission computed tomography (SPECT) dosimetry method in correlation with clinical outcome. Methods: 30 mCRPC patients were included (median 71 years). The dosimetry was performed for the first cycle using quantitative 177Lu-SPECT. The response was evaluated using RECIST 1.1 and PERCIST criteria, as well as changes in PSMA-positive tumor volume (PSMA-TV) in post-therapy PSMA-PET and biochemical response according to PSA changes after two RLT cycles. Results: Mean tumor doses as well as index-lesion doses were significantly higher in PERCIST responders compared to non-responders (10.2 ± 12.0 Gy/GBq vs. 4.0 ± 2.9 Gy/GBq, p = 0.03 and 13.7 ± 14.2 Gy/GBq vs. 5.9 ± 4.4 Gy/GBq, p = 0.04, respectively). No significant differences in mean tumor and index lesion doses were observed between responders and non-responders according to RECIST 1.1, PSMA-TV, and biochemical response criteria. Conclusion: Compared to mean tumor doses on a patient level, single index-lesion-based SPECT dosimetry correlates equally well with the response to PSMA-RLT according to PERCIST criteria and may represent a fast and feasible dosimetry approach for clinical routine.

scholarly journals Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

Hepatology ◽  
2008 ◽  
Vol 49 (1) ◽  
pp. 337-338 ◽  
Author(s):  
Lucy J. Walker ◽  
Julia Newton ◽  
David E. J. Jones ◽  
Margaret F. Bassendine
Keyword(s):  
Primary Biliary Cirrhosis ◽  
Ursodeoxycholic Acid ◽  
Biochemical Response ◽  
Biliary Cirrhosis ◽  
Long Term Prognosis
Sign in / Sign up

Export Citation Format

Share Document